Related Experiment Video
Updated: May 14, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
The Prevalence of Hypertension Among Children and Antihypertensive Use: Protocol for a Systematic Review and
Nur Hasnah Maamor1, Nur Ain Zahidah Zainudin2, Nur Liana Md Nasir3
1Sector for Evidence-based Healthcare, National Institutes of Health, Shah Alam, Malaysia.
Insights
This systematic review synthesizes global data on childhood hypertension (HT) prevalence and antihypertensive (anti-HT) use. Findings will inform strategies for preventing and managing this growing public health concern.
Area of Science:
- Pediatrics
- Cardiology
- Public Health
Background:
- Early-onset hypertension (HT) in children poses significant risks for lifelong cardiovascular and renal complications.
- Childhood HT is increasingly prevalent globally, yet often goes undetected due to measurement challenges.
- Existing prevalence estimates require comprehensive global synthesis.
Purpose of the Study:
- To systematically review and synthesize global evidence on the prevalence of childhood hypertension.
- To investigate the use of antihypertensive (anti-HT) medications in children.
- To evaluate the blood pressure-lowering effects of anti-HT treatments in pediatric populations.
Main Methods:
- A systematic review of observational and experimental studies, searching PubMed, CENTRAL, Embase, and Scopus databases until October 2024.
- Inclusion criteria: English language, full-text, peer-reviewed articles on children (0-18 years) with confirmed HT on at least three occasions.
- Data synthesis using STATA for pooled prevalence and RevMan for treatment effects, adhering to PRISMA and Joanna Briggs Institute guidelines.
Main Results:
- 14,575 articles were retrieved; analysis will report global and regional prevalence of childhood HT.
- Findings will detail risk factors, anti-HT medication use, and the efficacy of these treatments in lowering blood pressure in children.
- Results will be presented via summary tables and forest plots, with anticipated completion in mid-2025.
Conclusions:
- This review offers a crucial synthesis of childhood hypertension prevalence, highlighting it as a major public health issue.
- The findings will provide essential data to guide the development of effective prevention and management strategies for pediatric HT.
- This research aims to inform clinical practice and public health policy concerning childhood hypertension.
Background:
Early-onset hypertension (HT) presents compounded risks for cardiovascular, renal, and other systemic complications. Childhood HT is associated with HT during adulthood and detrimental lifelong cardiovascular disease events. However, most of the cases are not detectable as HT measurement in children is complicated and unstable. The global prevalence of HT among children is rapidly increasing. A previous study (2019) reported that the pooled global HT prevalence is 4.0% and the number is believed to be elevated. However, prevalence estimates of childhood HT have rarely been synthesized globally.
Objective:
This study aims to systematically pool all evidence from published articles and synthesize the evidence on the global prevalence of childhood HT and antihypertensive (anti-HT) use among children and its effects.
Methods:
This systematic review of observational and experimental studies will investigate the overall prevalence of HT and anti-HT use among children. We will search articles from 4 web-based databases: PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Embase, and Scopus using the specific keywords across the databases. During the article search conducted until October 2024, we retrieved 14,575 articles. Articles published in the English language with full text and are peer-reviewed journals included children aged between 0 and 18 years, confirmed with HT or high blood pressure (BP) on at least 3 separate occasions, and stated the definition of HT will be included in this protocol. Study selection and reporting will follow the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and the Meta-Analysis of Observational Studies in Epidemiology guidelines and Cochrane Risk of bias tool (ACROBAT) for experimental studies. Data will be extracted using a standardized data extraction form using Microsoft Excel software and the studies' quality will be assessed using the Joanna Briggs Institute's guideline according to the study design. We will use STATA software (version 17.0; StataCorp LLC) to calculate the global pooled prevalence and RevMan software (version 5.4; StataCorp LLC) to observe the effect of anti-HT use and BP among children. The risk of bias will be assessed using a funnel plot.
Results:
We retrieved 14,575 articles from 4 databases in October 2024. We will report the current global overall or pooled prevalence of HT as well as by region, risk factors, anti-HT use, and the anti-HT BP-lowering effect among the general children population. The findings will be presented in summary table findings and forest plot. This review is expected to be completed in the middle of 2025.
Conclusions:
This review will provide a comprehensive synthesis of the overall prevalence of HT among children-a public health issue of growing concern with long-term impact. This review will also provide important information to inform practice in developing effective strategies for preventing and managing childhood HT.
Trial Registration:
PROSPERO CRD42024500248; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024500248.
International Registered Report Identifier (Irrid):
PRR1-10.2196/65807.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hormonal Regulation
Factors affecting Blood pressure
Physiological Factors:
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

